81 related articles for article (PubMed ID: 30607586)
41. p16INK4A expression as biomarker for HPV 16-related vulvar neoplasias.
Riethdorf S; Neffen EF; Cviko A; Löning T; Crum CP; Riethdorf L
Hum Pathol; 2004 Dec; 35(12):1477-83. PubMed ID: 15619206
[TBL] [Abstract][Full Text] [Related]
42. p16 overexpression identifies HPV-positive vulvar squamous cell carcinomas.
Santos M; Landolfi S; Olivella A; Lloveras B; Klaustermeier J; Suárez H; Alòs L; Puig-Tintoré LM; Campo E; Ordi J
Am J Surg Pathol; 2006 Nov; 30(11):1347-56. PubMed ID: 17063073
[TBL] [Abstract][Full Text] [Related]
43. Implementation of p16/Ki67 dual stain cytology in a Danish routine screening laboratory: Importance of adequate training and experience.
Hammer A; Gustafson LW; Christensen PN; Brøndum R; Andersen B; Andersen RH; Tranberg M
Cancer Med; 2020 Nov; 9(21):8235-8242. PubMed ID: 32894896
[TBL] [Abstract][Full Text] [Related]
44. Immunocytochemical expression of Ki-67/p16 in normal, atypical, and neoplastic cells in urine cytology using BD SurePath™ as preparation method.
Østbye KM; Pedersen MK; Sauer T
Cytojournal; 2019; 16():26. PubMed ID: 31897084
[TBL] [Abstract][Full Text] [Related]
45. The Role of Photodynamic Therapy in the Treatment of Vulvar Intraepithelial Neoplasia.
Tosti G; Iacobone AD; Preti EP; Vaccari S; Barisani A; Pennacchioli E; Cantisani C
Biomedicines; 2018 Feb; 6(1):. PubMed ID: 29393881
[TBL] [Abstract][Full Text] [Related]
46. Assessment of Vulvar Intraepithelial Neoplasia (VIN) Grades Based on Dermoscopic Features: A Diagnostic Study.
De Giorgi V; Magnaterra E; Zuccaro B; Magliulo M; Maio V; Muccilli A; Venturi F; Stanganelli I; Massi D
Dermatol Pract Concept; 2023 Oct; 13(4):. PubMed ID: 37992378
[TBL] [Abstract][Full Text] [Related]
47. Initial evidence for Sec62 as a prognostic marker in advanced head and neck squamous cell carcinoma.
Wemmert S; Lindner Y; Linxweiler J; Wagenpfeil S; Bohle R; Niewald M; Schick B
Oncol Lett; 2016 Mar; 11(3):1661-1670. PubMed ID: 26998059
[TBL] [Abstract][Full Text] [Related]
48. Diagnosis of vulvar lesions by non-invasive optical analysis: a pilot study.
Vlastos AT; Charvet I; Dellacasa I; Capanna F; Pelte MF; Thueler P; Saint-Ghislain M; Depeursinge C; Meda P
Rare Tumors; 2009 Jul; 1(1):e8. PubMed ID: 21139902
[TBL] [Abstract][Full Text] [Related]
49. Immunoreactivity of TTF-1, GATA-3, CEA, and p16/Ki67 cocktail in Cellprep®-processed control samples: Comparison of long-term storage in vials and slides.
Ryu A; Honma K; Umeno Y; Uefuji F; Muramatsu T; Nishimura S; Tanada S; Yamamoto T; Nagata S; Yamasaki T; Ohue M
Diagn Cytopathol; 2024 Jan; 52(1):3-9. PubMed ID: 37740615
[TBL] [Abstract][Full Text] [Related]
50. Effect of the 3q26-coding oncogene
Radosa JC; Kasoha M; Schilz AC; Takacs ZF; Kaya A; Radosa MP; Linxweiler B; Linxweiler M; Bohle RM; Wagner M; Wagenpfeil G; Solomayer EF; Zimmermann JSM
Front Physiol; 2022; 13():1054508. PubMed ID: 36685175
[TBL] [Abstract][Full Text] [Related]
51. Antagonizing Sec62 function in intracellular Ca
Körner S; Pick T; Bochen F; Wemmert S; Körbel C; Menger MD; Cavalié A; Kühn JP; Schick B; Linxweiler M
Front Physiol; 2022; 13():880004. PubMed ID: 36045752
[TBL] [Abstract][Full Text] [Related]
52. On-chip immunofluorescence analysis of single cervical cells using an electroactive microwell array with barrier for cervical screening.
Takeuchi M; Nagasaka K; Yoshida M; Kawata Y; Miyagawa Y; Tago S; Hiraike H; Wada-Hiraike O; Oda K; Osuga Y; Fujii T; Ayabe T; Kim SH; Fujii T
Biomicrofluidics; 2019 Jul; 13(4):044107. PubMed ID: 31431817
[TBL] [Abstract][Full Text] [Related]
53. Coexpression of p53 and p16 in Vulvar Squamous Neoplasia.
Jeffus SK; Quick CM
Mod Pathol; 2023 Oct; 36(10):100319. PubMed ID: 37708626
[No Abstract] [Full Text] [Related]
54. Diagnostic utility of p16 immunocytochemistry for Trichomonas in urine cytology.
Pantanowitz L; Cao QJ; Goulart RA; Otis CN
Cytojournal; 2005 Jun; 2(1):11. PubMed ID: 15985185
[TBL] [Abstract][Full Text] [Related]
55. Comment on Kesić et al. Early Diagnostics of Vulvar Intraepithelial Neoplasia.
De Giorgi V; Magnaterra E; Magliulo M; Silvestri F; Venturi F; Zuccaro B; Colombo J; Trane L
Cancers (Basel); 2022 Oct; 14(20):. PubMed ID: 36291871
[TBL] [Abstract][Full Text] [Related]
56. Committee Opinion No. 675: Management of Vulvar Intraepithelial Neoplasia: Correction.
Obstet Gynecol; 2017 Jan; 129(1):209. PubMed ID: 28092302
[No Abstract] [Full Text] [Related]
57. A nonsurgical treatment for vulvar intraepithelial neoplasia.
Kent A
Rev Obstet Gynecol; 2008; 1(2):90. PubMed ID: 18769666
[No Abstract] [Full Text] [Related]
58. A missing opportunity to alleviate suffering: the case of vulvar cancer.
Allende-Pérez SR; Verástegui EL; Peña-Nieves A
Salud Publica Mex; 2023 Dec; 66(1, ene-feb):11-13. PubMed ID: 38065109
[No Abstract] [Full Text] [Related]
59. An integrated model for prognosis in vulvar squamous cell carcinoma.
Zhang T; Zhu Y; Luo J; Li J; Niu S; Chen H; Zhou F
BMC Cancer; 2023 Jun; 23(1):534. PubMed ID: 37308869
[TBL] [Abstract][Full Text] [Related]
60. The endoplasmic reticulum membrane protein Sec62 as potential therapeutic target in
Zimmermann JSM; Linxweiler J; Radosa JC; Linxweiler M; Zimmermann R
Front Physiol; 2022; 13():1014271. PubMed ID: 36262254
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
